Three pharmaceutical companies control the patent rights for the majority of insulin products on the market. These companies have over the past decade raised the price of insulin egregiously. As a result, many diabetics and their families are struggling to afford this life-saving medicine and, in some cases, taking desperate
3 min read
Subscribe to the Open Insulin Newsletter
Sign up for our quarterly newsletter for insights on the latest results from the lab, updates from our team, and news and stories from our community.